Reuters: New drugs still out of reach for most in India, world TB hotspot
“…The government approved the drug bedaquiline in January for about 500 patients under a national TB control program. It is intended for patients with an extremely resistant form of the infection and are immune to existing drugs. But it has no plans yet to make the drug available to the private sector, which is where more than half of the three million afflicted with the deadly infection go for treatment…” (Siddiqui, 3/20).